Exhibit 107
Calculation of Filing Fee Table
Form F-3
(Form Type)
ImmunoPrecise Antibodies Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
|
|
Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
|
Fees to Be Paid |
Equity |
Common Shares |
Rule 457(c) |
15,000,000(1) |
$0.7855(2) |
$11,782,500(2) |
$0.000147600 |
$1,739.10 |
|
Fees Previously Paid |
- |
- |
- |
|
|
- |
- |
- |
|
|
Total Offering Amounts |
|
$11,782,500 |
|
$1,739.10 |
|||
|
|
Total Fees Previously Paid |
|
|
|
- |
|||
|
|
Total Fee Offsets |
|
|
|
- |
|||
|
|
Net Fee Due |
|
|
|
$1,739.10 |
|||
|
(1) |
The securities are being registered solely in connection with the resale of Common Shares by the selling shareholder named in this registration statement. |
|
(2) |
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, based on the average of the high and low prices of the registrant's Common Shares on July 31, 2024, a date within five business days prior to the date of filing of this registration statement, as reported on the Nasdaq Global Market, which was approximately $0.7855 per share. |